News
Microplate Dx secures £2.5m for rapid diagnostic technology development
Glasgow diagnostics spinout, Microplate Dx, has secured £2.5m in seed funding to develop its point-of-care diagnostic platform to advance the effectiveness of antibiotics.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Glasgow diagnostics spinout, Microplate Dx, has secured £2.5m in seed funding to develop its point-of-care diagnostic platform to advance the effectiveness of antibiotics.